KP 1461

Drug Profile

KP 1461

Alternative Names: KP-1461; SN-1461

Latest Information Update: 21 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Koronis Pharmaceuticals
  • Class Antiretrovirals; Deoxyribonucleosides; Small molecules
  • Mechanism of Action HIV replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Suspended HIV infections

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 21 Oct 2010 Pharmacodynamics data from a phase IIa trial in HIV infections presented at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA-2010)
  • 29 Apr 2010 KP 1461 is available for licensing as of 29 Apr 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top